The absence of the delta-theta frequency biomarker in the nucleus accumbens during reduced food preoccupation in an individual treated with tirzepatide suggests that this biomarker reflects a state associated with heightened propensity for food preoccupation rather than a fixed trait.

When someone takes tirzepatide, it reaches parts of the brain that control cravings, and this changes how certain brain cells communicate in a slow rhythm. When this rhythm gets stronger, the person starts thinking about food more often and more intensely. When the rhythm weakens, those thoughts fade, even while still on the same medicine — meaning the brain’s activity changes with how much food is on the mind, not because the brain is permanently wired that way.